We will target the patients who are receiving treatment in Fujita Health University Hospital.
Conditions
Interventions
We will send reports called Report related to the efficacy of a medicine and anticipation of a side effect of medication which includes the genetic information of patients to attending doctors.
Sponsors
Iwata Nakao
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Patients who have obtained informed consent or assent according to their capacity to understand before participation in the study. 2 Patients at least 18 years of age at the time of consent. 3 Patients who are seen in any clinical department at Fujita Health University Hospital at present.
Exclusion criteria
Exclusion criteria: Not in particular
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We evaluate the attending doctors'prescription changes for drug selections or dosages related to the risk genetic variants based on the Report related to the efficacy of a medicine and anticipation of a side effect of medication.The endpoint is any changes in prescription in 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| We evaluate the attending doctors'prescription changes in every months for drug selections or dosages related to the risk genetic variants based on the Report related to the efficacy of a medicine and anticipation of a side effect of medication. The points set at 1,2,3,4 and 5 months after the enrollment and evaluate the trend for the timing of the prescription changes. | — |
Contacts
Public ContactMasami Miyata
FUJITA HEALTH UNIVERSITY
Outcome results
None listed